Pub. Date : 2011 Aug 1
PMID : 21693655
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | PATIENTS AND METHODS: Epithelial p53 expression was evaluated using two immunohistochemical antibodies (DO7 and 1801) in formalin-fixed, paraffin-embedded tissue from patients with node-positive breast cancer who were randomized to four cycles of cyclophosphamide and one of three doses of doxorubicin (60, 75, or 90 mg/m(2); AC) and to receive four subsequent cycles of paclitaxel (T) or not. | Paclitaxel | tumor protein p53 | Homo sapiens |
2 | CONCLUSION: Nuclear staining of p53 by immunohistochemistry is associated with worse prognosis in node-positive patients treated with adjuvant doxorubicin-based chemotherapy but is not a useful predictor of benefit from doxorubicin dose escalation or the addition of paclitaxel. | Paclitaxel | tumor protein p53 | Homo sapiens |